Purchase Order 75N95021P00418
Award Date 9/8/21
Potential Completion Date 12/8/21
Potential Value $23K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Westbury, NY 11590, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm-fixed-price purchase order contract was awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to the Southern Research Institute, a non-profit research organization. The $42,000 contract is for COVID-19 compound testing and cytotoxicity screening in the SARS-CoV-2 CPE assay. This work supports NCATS' mission of advancing the translation of medical discoveries into clinical applications. The contract has no...
- This $16,260.00 firm-fixed-price purchase order was awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to Cyprotex US LLC, a foreign-owned for-profit contract research organization. The contract is for COVID-19/coronavirus-related services, including method development for liquid chromatography-mass spectrometry (LC-MS/MS) analysis of 1 compound, and uptake transporter screening/identification for 2 concentrations and 2 time points using a...
- This firm-fixed-price purchase order contract, valued at $47,000.00, was awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to Southern Research Institute, a non-profit organization, for COVID-19 compound dose response testing. The contract has no set-aside designation and is part of NCATS' efforts to evaluate potential COVID-19 treatments. Southern Research Institute has a history of providing drug discovery, development, and testing services to...
- This is a $37,000 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Southern Research Institute. The contract is for COVID-19 compound testing and cytotoxicity screening in the SARS-CoV-2 CPE assay. This non-competitive award was made under simplified acquisition procedures, with the vendor selected due to prior work on the compound testing. The period of performance runs through...
- This firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) to Bioivt, LLC, a leading provider of biological specimens and services. The $183,092 contract is for a Transporter Substrate Assessment Study to support the development of a novel drug candidate. The study will characterize the metabolic profile and interaction potential of the drug candidate, following FDA guidance. This requirement was competitively solicited under the authority of FAR Part 12 and...
- The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a firm-fixed price purchase order to Fisher Scientific Company L.L.C. valued at $24,010.95 to provide multiple formulation-related laboratory tools and equipment. The solicitation requested brand name or equal laboratory items to support the agency's research and development efforts. Performance will take place in Potomac, Maryland over a three-month period...
- This federal contract award, ID 75N95020P00140, was issued by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to Columbia Biosciences Corp. It is a Firm Fixed Price purchase order with a ceiling value of $49,068.00. The purpose of the contract is to provide an HTRF (Homogeneous Time-Resolved Fluorescence) assay for the detection of SARS-CoV-2. The contract has an ultimate completion date of May 6, 2020 and was awarded on March 24, 2020. The place of...
- This federal contract award, valued at $79,000.00, was issued by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to the Southern Research Institute, a non-profit organization, for "HIGH-THROUGHPUT SARS-COV-2 ALPHALISA SCREENING FOR COVID-19 DRUG DISCOVERY - ANTIVIRAL INITIATIVE". The contract has a firm fixed price and was awarded on a non-competitive basis with no set-aside designation. Based on the agency and description, this contract supports...
- This is a $91,900 firm-fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to QPS LLC, a minority-owned limited liability company, for COVID-19-related bioanalytical testing services. The contract involves LC-MS/MS method development, qualification, sample analysis, and sample re-analysis for remdesivir and related compounds. The contract was awarded on a sole-source basis without full and open...
- This firm fixed-price purchase order was awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to Southern Research Institute to conduct COVID-19 compound testing and cytotoxicity screening in the SARS-CoV-2 cytopathic effect (CPE) assay across two rounds. The $74,000.00 contract has an ultimate completion date of August 28, 2020 and was not set aside for any specific business type. Southern Research Institute is a...